RT Journal Article
SR Electronic
T1 High-Resolution Digital Phenotypes from Consumer Wearables Enhance Prediction of Cardiometabolic Risk Markers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.29.21265547
DO 10.1101/2021.10.29.21265547
A1 Zhou, Weizhuang
A1 Chan, Yu En
A1 Foo, Chuan Sheng
A1 Zhang, Jingxian
A1 Teo, Jing Xian
A1 Davila, Sonia
A1 Huang, Weiting
A1 Yap, Jonathan
A1 Cook, Stuart A.
A1 Tan, Patrick
A1 Chin, Calvin Woon-Loong
A1 Yeo, Khung Keong
A1 Lim, Weng Khong
A1 Krishnaswamy, Pavitra
YR 2021
UL http://medrxiv.org/content/early/2021/11/01/2021.10.29.21265547.abstract
AB Background Consumer-grade wearable devices enable detailed recordings of heart rate and step counts in free-living conditions. Recent studies have shown that summary statistics from these wearable recordings have potential uses for longitudinal monitoring of health and disease states. However, the relationship between higher resolution physiological dynamics from wearables and known markers of health and disease remains largely uncharacterized.Objective We aimed to (i) derive high resolution digital phenotypes from observational wearable recordings, (ii) characterize their ability to predict modifiable markers of cardiometabolic disease, and (iii) study their connections with genetic predispositions for cardiometabolic disease and with lifestyle factors.Methods We introduce a principled framework to extract interpretable high resolution phenotypes from wearable data recorded in free-living conditions. The proposed framework standardizes handling of data irregularities, encodes contextual information about underlying physiological state at any given time, and generates a set of 66 minimally redundant features across active, sedentary and sleep states. We applied our approach on a multimodal dataset, from the SingHEART study (NCT02791152), that comprises of heart rate and step count time series from wearables, clinical screening profiles, whole genome sequences and lifestyle survey responses from 692 healthy volunteers. We employed machine learning to model non-linear relationships between the high resolution phenotypes and clinical risk markers for blood pressure, lipid and weight abnormalities. For each risk type, we performed model comparisons based on Brier Skill Scores (BSS) to assess predictive value of the high resolution features over and beyond typical baselines. We then examined associations between the wearable-derived features, polygenic risk for cardiometabolic disease, and lifestyle habits and health perceptions.Results Compared to typical summary statistic measures like resting heart rate, we find that the high-resolution features collectively have greater predictive value for modifiable clinical markers associated with cardiometabolic disease risk (average improvement in Brier Skill Score=52.3%, P<.001). Further, we show that heart rate dynamics from different activity states contain distinct information about type of cardiometabolic risk, with dynamics in sedentary states being most predictive of lipid abnormalities and patterns in active states being most predictive of blood pressure abnormalities (P<.001). Finally, our results reveal that subtle heart rate dynamics in wearable recordings serve as physiological correlates of genetic predisposition for cardiometabolic disease, lifestyle habits and health perceptions.Conclusions High resolution digital phenotypes recorded by consumer wearables in free-living states have the potential to enhance prediction of cardiometabolic disease risk, and could enable more proactive and personalized health management.Trial Registration ClinicalTrials.gov NCT02791152; https://clinicaltrials.gov/ct2/show/NCT02791152Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Singapore National Precision Medicine programme (IAF-PP H17/01/a0/007), and the Institute for Infocomm Research, A*STAR. The data acquisition was supported in part by funding from SingHealth, Duke-NUS Medical School, National Heart Centre Singapore (NHCS), Singapore National Medical Research Council (NMRC/STaR/0011/2012, NMRC/STaR/0026/2015), Lee Foundation, and Tanoto Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of SingHealth gave ethical approval for this work. (CIRB Ref: 2015/2601 and 2018/3081)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsPGSPolygenic ScoreECGElectrocardiogramICD-10International Classification of Diseases, 10th Revision